Stock Research for PTLA


Featured Broker: Ally Invest

Get the due diligence for another stock.


PTLA Stock Chart & Research Data

The PTLA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PTLA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


PTLA Due diligence Resources & Stock Charts

The PTLA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PTLA Detailed Price Forecast - CNN Money CNN View PTLA Detailed Summary - Google Finance
Yahoo View PTLA Detailed Summary - Yahoo! Finance Zacks View PTLA Stock Research & Analysis -

Stock Analysis

TradeIdeas View PTLA Trends & Analysis - Trade-Ideas Barrons View PTLA Major Holders - Barrons
NASDAQ View PTLA Call Transcripts - NASDAQ Seeking View PTLA Breaking News & Analysis - Seeking Alpha
Spotlight View PTLA Annual Report - OTC Report View PTLA OTC Short Report -
TradeKing View PTLA Fundamentals - TradeKing Charts View PTLA SEC Filings - Bar Chart
WSJ View Historical Prices for PTLA - The WSJ Morningstar View Performance/Total Return for PTLA - Morningstar
MarketWatch View the Analyst Estimates for PTLA - MarketWatch CNBC View the Earnings History for PTLA - CNBC
StockMarketWatch View the PTLA Earnings - StockMarketWatch MacroAxis View PTLA Buy or Sell Recommendations - MacroAxis
Bullish View the PTLA Bullish Patterns - American Bulls Short Pains View PTLA Short Pain Metrics -

Social Media Mentions

StockTwits View PTLA Stock Mentions - StockTwits PennyStocks View PTLA Stock Mentions - PennyStockTweets
Twitter View PTLA Stock Mentions - Twitter Invest Hub View PTLA Investment Forum News - Investor Hub
Yahoo View PTLA Stock Mentions - Yahoo! Message Board Seeking Alpha View PTLA Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for PTLA - Insider Cow View Insider Transactions for PTLA - Insider Cow
CNBC View PTLA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PTLA - OTC Markets
Yahoo View Insider Transactions for PTLA - Yahoo! Finance NASDAQ View Institutional Holdings for PTLA - NASDAQ

Stock Charts

FinViz View PTLA Stock Insight & Charts - StockCharts View PTLA Investment Charts -
BarChart View PTLA Stock Overview & Charts - BarChart Trading View View PTLA User Generated Charts - Trading View

Latest Financial News for PTLA

Why Portola Pharmaceuticals Stock Shed 11% in September
Posted on Thursday October 11, 2018

The biotech specialist is transitioning to a new management team under difficult operating conditions.

What You Must Know About Portola Pharmaceuticals Inc’s (NASDAQ:PTLA) Market Risks
Posted on Tuesday October 09, 2018

If you own shares in Portola Pharmaceuticals Inc (NASDAQ:PTLA) then it’s worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure

Portola Pharmaceuticals Supports 2018 World Thrombosis Day Campaign to Raise Awareness of Blood Clots as an Urgent and Growing Health Crisis
Posted on Tuesday October 09, 2018

Portola Pharmaceuticals, Inc.® (PTLA) today announced its 2018 partnership with the World Thrombosis Day campaign to help raise global awareness of thrombosis. Observed annually on October 13, World Thrombosis Day is led by the International Society on Thrombosis and Haemostasis (ISTH), which has mobilized more than 1,500 partner organizations worldwide this year to shine a spotlight on the burden of arterial or venous thrombosis – the potentially life-threatening formation of blood clots in an artery or vein – and conditions caused by it.

Recent Developments for Portola Pharmaceuticals
Posted on Monday October 08, 2018

In September 2018, the US FDA granted Portola Pharmaceuticals’ cerdulatinib, an investigational Syk/JAK inhibitor, an orphan drug designation for peripheral T-cell lymphoma (or PTCL) therapy. The FDA grants this designation to support the development of therapies for rare diseases. This designation provides benefits such as seven years of market exclusivity after approval, tax credits for certain clinical trials, and exemption of FDA application fees.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.